Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line
Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line
复制标题
DOI:
10.1074/jbc.272.35.22199
复制
发表时间:
1997-08-29
影响因子:
4.8
通讯作者:
Sakai, T
中科院分区:
文献类型:
--
作者:
Nakano, K;Mizuno, T;Sakai, T
Butyrate is a well known colonic luminal short chain fatty acid, which arrests cell growth and induces differentiation in various cell types. We examined the effect of butyrate on the expression of WAF1/Cip1, a potent inhibitor of cyclin-dependent kinases, and its relation to growth arrest in a p53-mutated human colon cancer cell line WiDr, Five millimolar butyrate completely inhibited the growth of WiDr and caused G(1)-phase arrest. WAF1/Cip1 mRNA was rapidly induced within 3 h by treatment with 5.0 mM butyrate, and drastic WAF1/Cip1 protein induction was detected. Using several mutant WAF1/Cip1 promoter fragments, we found that the butyrate responsive elements are two Spl sites at -82 and -69 relative to the transcription start site. We also found that a TATA element at -46 and two overlapping consensus Spl sites at -60 and -55 are essential for the basal promoter activity of WAF1/Cip1. These findings suggest that butyrate arrests the growth of WiDr by activating the WAF1/Cip1 promoter through specific Sp1 sites in a p53-independent fashion.